Measurable Solutions For Health Equity
The goal of the Beacon of Hope initiative is to co-create effective, measurable solutions for health equity, focusing in three key areas:
Disparities are endemic across our healthcare system. Novartis and the Novartis US Foundation took a major step forward to address the root causes of disparities in health and education by launching Beacon of Hope, an innovative ten-year collaboration initially with 26 Historically Black Colleges and Universities (HBCUs), including four HBCU Medical Schools, plus Merck, Sanofi, the National Medical Association, Thurgood Marshall College Fund, and Coursera. This year, Novartis and the Novartis US Foundation are proud to welcome The Global Black Economic Forum, Advarra, Virb, BeeKeeperAI, Amgen and Alnylam to Beacon of Hope.
Enabling the Next Generation of Leaders
The Beacon of Hope collaboration has made significant progress in empowering the next generation of African American, Black and Hispanic students to become healthcare leaders.
Clinical Trials Centers of Excellence
The program establishes clinical trial Centers of Excellence at the four Historically Black Medical Schools to increase diversity among clinical trial investigators and participants.
Research Centers of Excellence
In addition to promoting diversity in clinical trials, Beacon of Hope is supporting the creation of two additional Centers of Excellence at Morehouse School of Medicine.
A Message From Linda
Read about the exciting next chapter for Beacon of Hope from Linda Armstrong, MD, US Novartis Foundation President and Lead, US Corporate Responsibility at Novartis Pharmaceutical Corporation.
Beacon of Hope Pledge
Stakeholders who signed the original Beacon of Hope Pledge committed to collaboration in finding solutions to addressing systemic disparities in education and health outcomes to create greater diversity, equity and inclusion across the research and development ecosystem.